date:Sep 26, 2013
.
A statement from China's health ministry last week said it would crack down on hospital sales tactics and punish staff who accepted bribes.
This could result in a slowdown of sales and marketing activity in hospitals for infant formula and hit sales performance, said Katherine Wang, chief China life sciences advisor for law firm Ropes Gray.
Recent investigations into bribery in the pharmaceutical sector have hit sales operations and dented revenues for Chinese and international drug firms.